165 related articles for article (PubMed ID: 16391296)
1. Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry.
Wachtel M; Runge T; Leuschner I; Stegmaier S; Koscielniak E; Treuner J; Odermatt B; Behnke S; Niggli FK; Schäfer BW
J Clin Oncol; 2006 Feb; 24(5):816-22. PubMed ID: 16391296
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of EGFR, fibrillin-2, P-cadherin and AP2beta as biomarkers for rhabdomyosarcoma diagnostics.
Grass B; Wachtel M; Behnke S; Leuschner I; Niggli FK; Schäfer BW
Histopathology; 2009 Jun; 54(7):873-9. PubMed ID: 19469909
[TBL] [Abstract][Full Text] [Related]
3. Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications.
van Gaal JC; Flucke UE; Roeffen MH; de Bont ES; Sleijfer S; Mavinkurve-Groothuis AM; Suurmeijer AJ; van der Graaf WT; Versleijen-Jonkers YM
J Clin Oncol; 2012 Jan; 30(3):308-15. PubMed ID: 22184391
[TBL] [Abstract][Full Text] [Related]
4. Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS).
Smith LM; Anderson JR; Coffin CM
Med Pediatr Oncol; 2002 Jun; 38(6):398-404. PubMed ID: 11984800
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study.
Lee JS; Lim SM; Rha SY; Roh JK; Cho YJ; Shin KH; Yang WI; Kim SH; Kim HS
J Clin Pathol; 2014 Jan; 67(1):33-9. PubMed ID: 23922356
[TBL] [Abstract][Full Text] [Related]
6. Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior.
Staibano S; Franco R; Tranfa F; Mezza E; Lo Muzio L; Strianese D; Errico ME; Bufo P; Ferrara G; Somma P; Mansueto G; Greco I; Fiorillo A; Bonavolontà G; De Rosa G
Anticancer Res; 2004; 24(1):249-57. PubMed ID: 15015604
[TBL] [Abstract][Full Text] [Related]
7. Pathologic features of rhabdomyosarcoma before and after treatment: a clinicopathologic and immunohistochemical analysis.
Coffin CM; Rulon J; Smith L; Bruggers C; White FV
Mod Pathol; 1997 Dec; 10(12):1175-87. PubMed ID: 9436961
[TBL] [Abstract][Full Text] [Related]
8. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
9. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
[TBL] [Abstract][Full Text] [Related]
10. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group.
Chiles MC; Parham DM; Qualman SJ; Teot LA; Bridge JA; Ullrich F; Barr FG; Meyer WH;
Pediatr Dev Pathol; 2004; 7(6):583-94. PubMed ID: 15630526
[TBL] [Abstract][Full Text] [Related]
11. Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues.
Kumar S; Perlman E; Harris CA; Raffeld M; Tsokos M
Mod Pathol; 2000 Sep; 13(9):988-93. PubMed ID: 11007039
[TBL] [Abstract][Full Text] [Related]
12. The role of nuclear morphometry in prediction of prognosis for rhabdomyosarcoma in children.
Kazanowska B; Jelen M; Reich A; Tarnawski W; Chybicka A
Histopathology; 2004 Oct; 45(4):352-9. PubMed ID: 15469473
[TBL] [Abstract][Full Text] [Related]
13. Kit expression in spindle cell rhabdomyosarcoma can possibly create a different approach for its tumorigenesis and therapy.
Diniz G; Aktas S; Ortac R; Tunakan M; Unlu I; Vergin C
Pathol Res Pract; 2006; 202(9):671-7. PubMed ID: 16860492
[TBL] [Abstract][Full Text] [Related]
14. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
Paner GP; McKenney JK; Epstein JI; Amin MB
Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of a muscle ankyrin-repeat protein, Arpp, in paraffin-embedded tumors: evaluation of Arpp as a tumor marker for rhabdomyosarcoma.
Ishiguro N; Motoi T; Osaki M; Araki N; Minamizaki T; Moriyama M; Ito H; Yoshida H
Hum Pathol; 2005 Jun; 36(6):620-5. PubMed ID: 16021567
[TBL] [Abstract][Full Text] [Related]
16. Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis.
Stock N; Chibon F; Binh MB; Terrier P; Michels JJ; Valo I; Robin YM; Guillou L; Ranchère-Vince D; Decouvelaere AV; Collin F; Birtwisle-Peyrottes I; Gregoire F; Aurias A; Coindre JM
Am J Surg Pathol; 2009 Dec; 33(12):1850-9. PubMed ID: 19898221
[TBL] [Abstract][Full Text] [Related]
17. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic abnormalities in 42 rhabdomyosarcoma: a United Kingdom Cancer Cytogenetics Group Study.
Gordon T; McManus A; Anderson J; Min T; Swansbury J; Pritchard-Jones K; Shipley J; ;
Med Pediatr Oncol; 2001 Feb; 36(2):259-67. PubMed ID: 11452933
[TBL] [Abstract][Full Text] [Related]
19. Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group.
Davicioni E; Anderson MJ; Finckenstein FG; Lynch JC; Qualman SJ; Shimada H; Schofield DE; Buckley JD; Meyer WH; Sorensen PH; Triche TJ
Am J Pathol; 2009 Feb; 174(2):550-64. PubMed ID: 19147825
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components.
Sarkaria IS; Zakowski MF; Pham D; Hezel M; Ebright MI; Chuai S; Venkatraman ES; Kris MG; Rusch VW; Singh B
Ann Thorac Surg; 2008 Jan; 85(1):216-23. PubMed ID: 18154814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]